PRODUCTION OF NOVEL 17 BETAAESTER OF NANDROLONE AND NOVEL PHARMACEUTICAL AGENT CONTAINING SAME WITH ASSIMIRATING ACTION

摘要

The invention relates to a novel pharmaceutical preparation with anabolic activity adapted for oral administration comprising a nandrolone (= 19-nor-testosterone)-17 beta -ester, the ester group of which has been derived from aliphatic carboxylic acids having 9-18 carbon atoms, in combination with a non-steroidal lipoid. The preparation may additionally contain a mineralocorticoid steroid. The invention also relates to novel nandrolone-17 beta -esters.